Sudhir Raghavan

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Capillary Electrophoresis

Locally Advanced

Recombinant Human

Top Venues

Molecular cancer therapeutics

Molecules (Basel, Switzerland)

Houston Methodist Research Institute

Duquesne University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Houston Methodist Research Institute

United States

Instructor :: Neurosurgery

Education History

Duquesne University

United States

PHD :: Pharmaceutical Sciences

Publications

Sudhir Raghavan, David S Baskin, Martyn A Sharpe
MP-Pt(IV): A MAOB-Sensitive Mitochondrial-Specific Prodrug for Treating Glioblastoma. Molecular cancer therapeutics 19 (12) (2020)
Federica Pisaneschi, Yu-Hsi Lin, Paul G Leonard, Nikunj Satani, Victoria C Yan, Naima Hammoudi, Sudhir Raghavan, Todd M Link, Dimitra K Georgiou, Barbara Czako, Florian L Muller
The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues. Molecules (Basel, Switzerland) 24 (13) (2019)